Latest Cost Reduction News

Page 5 of 81
Immutep has identified structural differences between the efti used in its failed TACTI-004 Phase III trial and batches used in earlier successful studies, prompting a new 200 L manufacturing run. The biotech is narrowing efti’s future development focus while elevating autoimmune candidate IMP761 to co-priority status.
Ada Torres
Ada Torres
29 Oct 2026
Adheris Health delivered a stronger first quarter on revenue, margins and its CY27 sales pipeline, but ended September with US$3.5 million in cash after a US$3.1 million operating outflow. The company also disclosed the impending loss of a major pharmacy partner and a US$2.3 million-plus legal claim.
Ada Torres
Ada Torres
28 Oct 2026
Botanix’s Sofdra prescriptions rose 5.3% in the September quarter, but flat net revenue and a sharp cash decline have forced a major reset. The company is targeting a roughly 50% reduction in operating expenses while assessing licensing, acquisitions and broader strategic transactions.
Victor Sage
Victor Sage
27 Oct 2026
IDP Education has reaffirmed FY27 Adjusted EBIT guidance of A$95 million to A$115 million after using cost control, stronger yields and cash generation to cushion another sharp fall in international student volumes. The AGM also disclosed that the board had rejected an unsolicited acquisition proposal and had completed about A$11 million of a planned A$50 million buyback.
Victor Sage
Victor Sage
27 Oct 2026
OFX’s proposed $1.00-per-share takeover by Equals has lost its exclusivity after the UK bidder failed to reconfirm its proposal by the agreed deadline. Meanwhile, quarterly net operating income improved sequentially but remained well below the prior year, with enterprise revenue falling sharply and available cash declining.
Claire Turing
Claire Turing
26 Oct 2026
Dubber reported $1.3 million of positive operating cash flow in Q1 FY27, alongside $7.7 million in revenue and $16.2 million of total liquidity. The company is now shifting from cost reduction towards growth, with new AI products and the proposed Daisee acquisition next in line.
Sophie Babbage
Sophie Babbage
26 Oct 2026
C29 Metals ended September with $219,000 in cash and estimated funding for just 0.59 quarters, while its proposed $2.4 million placement remains subject to shareholder approval. The explorer reported no on-site exploration during the quarter, as it moved to cut costs and rationalise its portfolio.
Maxwell Dee
Maxwell Dee
23 Oct 2026
Adslot reported stronger Viber advertising activity and lower operating costs in the September quarter, while restructuring payments continued to weigh on cash. The company ended the period with $1.28 million and a prescribed funding runway of 1.7 quarters.
Victor Sage
Victor Sage
23 Oct 2026
Whitehaven Coal has opened FY27 with a 22% year-on-year jump in managed ROM production, while terminal disruptions pushed equity sales lower and lifted inventories. Costs remained at the low end of guidance, prices strengthened and full-year targets were unchanged.
Maxwell Dee
Maxwell Dee
23 Oct 2026
Black Cat Syndicate maintained its FY27 production and cost guidance despite a capital-heavy quarter that pushed cash and liquid investments down by A$27.7 million. Paulsens remained steady, while Kal East’s ramp-up and a new A$30 million cash improvement program now dominate the execution story.
Maxwell Dee
Maxwell Dee
23 Oct 2026
Bapcor says its operational reset is beginning to show through, with first-quarter Trade sales up 2.5%, margins improving and net debt falling to $116 million. The recovery remains early, however, with Retail still under pressure and FY27 earnings weighted heavily to the second half.
Victor Sage
Victor Sage
22 Oct 2026
CurveBeam AI has secured its strongest first-quarter HiRise sales result, gained China regulatory clearance and raised A$7.35 million to fund the next stage of commercialisation. The progress comes alongside lower customer receipts and a reported 4.3 quarters of cash runway.
Victor Sage
Victor Sage
21 Oct 2026

Browse the archive

Full archive